Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study

Jesús G. Berdeja, Sundar Jagannath, Jeffrey A. Zonder, Ashraf Badros, Jonathan L. Kaufman, Robert Manges, Manish Gupta, Amol Tendolkar, Mark Lynch, Eric Bleickardt,

Clinical Lymphoma Myeloma & Leukemia · 2015 · 69 citations · 22 references

DOIFull text

Open access

Concepts

References

22